Haemonetics Sets Date for Publishing First Quarter Fiscal Year 2022 Results: August 11, 2021
Haemonetics Corporation (NYSE: HAE) announced it will release its first quarter fiscal year 2022 financial results on August 11, 2021, at 6:00 am EDT.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Haemonetics Corporation (NYSE: HAE) announced it will release its first quarter fiscal year 2022 financial results on August 11, 2021, at 6:00 am EDT. Following this, a conference call will take place at 8:00 am EDT on the same day to discuss the results and answer questions. Investors can access the call via a toll-free number or through an online webcast. A replay will be available for one year starting from August 11, 2021, at 11:00 am EDT.
Details
News Market Reaction – HAE
The recorded move for HAE in the trading session of this news was +0.83%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BOSTON, July 9, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish first quarter fiscal year 2022 financial results at 6:00 am EDT on Wednesday, August 11, 2021. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am EDT on August 11, 2021.
The call can be accessed with the following information:
U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
Conference ID required for access: 1674067
A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/m6/p/qyrbnnofhttps://edge.media-server.com/mmc/p/i5w7z4hk
A replay of the conference call and webcast will be available for one year beginning on August 11, 2021 at 11:00 a.m. EDT using the conference call webcast link provided in this press release.
About Haemonetics
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers to help them improve patient care and reduce the cost of healthcare. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contact:
Olga Guyette, Director-Investor Relations
(781) 356-9763
olga.guyette@haemonetics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-first-quarter-fiscal-year-2022-results-august-11-2021-301328843.html
SOURCE Haemonetics Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.